Issue Information.
- Published in:
- JBMR Plus, 2019, v. 3, n. 12, p. N.PAG, doi. 10.1002/jbm4.10323
- Publication type:
- Article
Works matching IS 24734039 AND DT 2019 AND VI 3 AND IP 12
Results: 8
1
2
Effects of Intermittent Administration of Parathyroid Hormone and Parathyroid Hormone‐Related Protein on Fracture Healing: A Narrative Review of Animal and Human Studies.
- Published in:
- JBMR Plus, 2019, v. 3, n. 12, p. N.PAG, doi. 10.1002/jbm4.10250
- By:
- Publication type:
- Article
3
Accelerated Cortical Osteolysis of Metatarsals in Charcot Neuroarthropathy: A Cross‐Sectional Observational Study.
- Published in:
- JBMR Plus, 2019, v. 3, n. 12, p. N.PAG, doi. 10.1002/jbm4.10243
- By:
- Publication type:
- Article
4
Genetic Dissection of Femoral and Tibial Microarchitecture.
- Published in:
- JBMR Plus, 2019, v. 3, n. 12, p. N.PAG, doi. 10.1002/jbm4.10241
- By:
- Publication type:
- Article
5
Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study.
- Published in:
- JBMR Plus, 2019, v. 3, n. 12, p. N.PAG, doi. 10.1002/jbm4.10240
- By:
- Publication type:
- Article
6
Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical Trials.
- Published in:
- JBMR Plus, 2019, v. 3, n. 12, p. N.PAG, doi. 10.1002/jbm4.10239
- By:
- Publication type:
- Article
7
Does the Prediction Accuracy of Osteoporotic Fractures by BMD and Clinical Risk Factors Vary With Fracture Site?
- Published in:
- JBMR Plus, 2019, v. 3, n. 12, p. N.PAG, doi. 10.1002/jbm4.10238
- By:
- Publication type:
- Article
8
In Vivo Bone Effects of a Novel Bisphosphonate‐EP4a Conjugate Drug (C3) for Reversing Osteoporotic Bone Loss in an Ovariectomized Rat Model.
- Published in:
- JBMR Plus, 2019, v. 3, n. 12, p. N.PAG, doi. 10.1002/jbm4.10237
- By:
- Publication type:
- Article